NRx Pharmaceuticals, Inc. (NRXP)
NRx Pharmaceuticals, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
NRx Pharmaceuticals, Inc. (NRXP) is a Biotechnology company based in US with a market capitalization of $77.1M. Free cash flow was negative at -$14.1M. This page tracks NRXP's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 2 employees · IPO Dec 4, 2017
Valuation
Valuation & price
$3.28as of May 17, 2026· -29.0% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
—
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$77.1M
Market cap
—
Revenue growth (YoY)
58.8%
Gross margin
-$14.1M
Free cash flow (USD)
-$7.2M
Net debt
Net cash position
103.5%
Share dilution
0/4
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2025
Free cash flow by year
2017 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.04)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is NRx Pharmaceuticals, Inc.'s market cap?
NRx Pharmaceuticals, Inc. (NRXP) has a market capitalization of $77.1M.
What is NRXP's P/E ratio?
A meaningful P/E ratio is not available for NRXP — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
When did NRx Pharmaceuticals, Inc. last report earnings?
NRXP last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying NRXP stock?
SEC Form 4 filings show no open-market insider buys at NRx Pharmaceuticals, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.